LYFE Capital, a venture fund established in 2014, operates in Shanghai, China, with a focus on BioTech, Life Science, Healthcare, and Medical Device sectors. The fund, led by Partner James Zhao, invests in companies at Seed, Series A, and Series B stages. LYFE Capital has invested in 43 companies like Kyverna Therapeutics and Ansun BioPharma, with 5 successful exits. For more information, visit their website at www.lyfecapital.com/en/.